We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Moelis & Co
MC
$4.91B
| $851K | ﹤0.01% |
22,150
+3,250
| +17% | +$140K |
|
1377
Genworth Financial
GNW
$3.84B
| $851K | ﹤0.01% |
169,520
| – | – |
|
|
INVX
1378
Innovex International
INVX
$1.8B
| $847K | ﹤0.01% |
29,513
| – | – |
|
1379
Welltower
WELL
$173B
| $846K | ﹤0.01% |
11,800
| – | – |
|
1380
Brookfield Asset Management
BAM
$75.4B
| $846K | ﹤0.01% |
25,769
+8,700
| +51% | +$283K |
|
1381
Seacoast Banking Corp of Florida
SBCF
$3.29B
| $845K | ﹤0.01% |
35,660
+7,150
| +25% | +$213K |
|
1382
Stepan Co
SCL
$1.41B
| $844K | ﹤0.01% |
8,196
+1,300
| +19% | +$137K |
|
1383
ICF International
ICFI
$1.48B
| $844K | ﹤0.01% |
7,690
+1,050
| +16% | +$109K |
|
1384
Kulicke & Soffa
KLIC
$4.43B
| $843K | ﹤0.01% |
16,004
+1,100
| +7% | +$57.2K |
|
|
COOP
1385
DELISTED
Mr. Cooper
COOP
| $842K | ﹤0.01% |
20,560
| – | – |
|
1386
Fastly Inc
FSLY
$3.17B
| $842K | ﹤0.01% |
+47,400
| New | +$602K |
|
1387
Freshworks
FRSH
$3.17B
| $841K | ﹤0.01% |
54,750
+2,350
| +4% | +$35.6K |
|
1388
First Interstate BancSystem
FIBK
$3.66B
| $841K | ﹤0.01% |
28,150
+7,750
| +38% | +$273K |
|
|
AXNX
1389
DELISTED
Axonics, Inc. Common Stock
AXNX
| $840K | ﹤0.01% |
15,400
| – | – |
|
1390
Corcept Therapeutics
CORT
$10B
| $839K | ﹤0.01% |
38,750
+1,250
| +3% | +$27.4K |
|
|
CPRX
1391
DELISTED
Catalyst Pharmaceutical
CPRX
| $839K | ﹤0.01% |
50,590
| – | – |
|
1392
John B. Sanfilippo & Son
JBSS
$991M
| $837K | ﹤0.01% |
8,633
+850
| +11% | +$75.9K |
|
1393
Hertz
HTZ
$502M
| $834K | ﹤0.01% |
51,210
-182
| -0.4% | -$3.17K |
|
|
ALEX
1394
DELISTED
Alexander & Baldwin
ALEX
| $834K | ﹤0.01% |
44,113
+3,900
| +10% | +$73.9K |
|
1395
National Health Investors
NHI
$3.83B
| $834K | ﹤0.01% |
16,160
+800
| +5% | +$43.6K |
|
1396
Kontoor Brands
KTB
$4.71B
| $833K | ﹤0.01% |
17,210
| – | – |
|
|
RPTX
1397
DELISTED
Repare Therapeutics
RPTX
| $832K | ﹤0.01% |
84,603
| – | – |
|
|
HTO
1398
H2O America
HTO
$2.71B
| $830K | ﹤0.01% |
10,900
+250
| +2% | +$19.3K |
|
1399
Sunstone Hotel Investors
SHO
$2.21B
| $826K | ﹤0.01% |
83,570
| – | – |
|
1400
Fulton Financial
FULT
$4.68B
| $826K | ﹤0.01% |
59,740
+1,200
| +2% | +$19.4K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.